VAN VOORHEES SETH 4
4 · NRX Pharmaceuticals, Inc. · Filed Nov 28, 2022
Insider Transaction Report
Form 4
VAN VOORHEES SETH
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.10/sh+600$660→ 9,316 total(indirect: By 401(k)) - Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.11/sh+7,021$7,793→ 16,377 total(indirect: By 401(k)) - Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.12/sh+8,716$9,762→ 8,716 total(indirect: By 401(k))